购物车
- 全部删除
您的购物车当前为空
Anti-RANKL/TNFSF11/CD254 Antibody (5P597)
还可以产品编号 TMAY-01992
Anti-RANKL/TNFSF11/CD254 Antibody (5P597) 是一种 Rabbit 抗体，靶向 RANKL/TNFSF11/CD254。Anti-RANKL/TNFSF11/CD254 Antibody (5P597) 可用于 ELISA(Cap)。
Anti-RANKL/TNFSF11/CD254 Antibody (5P597)
Anti-RANKL/TNFSF11/CD254 Antibody (5P597)
还可以产品编号 TMAY-01992
Anti-RANKL/TNFSF11/CD254 Antibody (5P597) 是一种 Rabbit 抗体，靶向 RANKL/TNFSF11/CD254。Anti-RANKL/TNFSF11/CD254 Antibody (5P597) 可用于 ELISA(Cap)。
产品信息正在更新中，如果您想购买，请点击大包装&定制按钮.
大包装 & 定制
联系我们获取更多批次信息
资源下载
产品介绍
生物活性
偶联与修饰
抗原信息
| 产品描述 | Anti-RANKL/TNFSF11/CD254 Antibody (5P597) is a Rabbit antibody targeting RANKL/TNFSF11/CD254. Anti-RANKL/TNFSF11/CD254 Antibody (5P597) can be used in ELISA(Cap). |
| Ig Type | Monoclonal Rabbit IgG |
| 克隆号 | 5P597 |
| 交叉反应 | Human |
| 应用 | ELISA(Cap) |
| 抗体种类 | Monoclonal |
| 宿主来源 | Rabbit |
| 构建方式 | This antibody was obtained from a rabbit immunized with purified, recombinant Human RANKL / OPGL / TNFSF11 / CD254 (rh RANKL / OPGL / TNFSF11 / CD254; TMPY-03364; AAC51762.1;Gly64-Asp245). |
| 纯化方式 | Protein A |
| 性状 | Liquid |
| 缓冲液 | 0.2 μm filtered solution in PBS |
| 研究背景 | Tumor necrosis factor ligand superfamily member 11, also known as Receptor activator of nuclear factor kappa-B ligand, Osteoprotegerin ligand, TNFSF11, RANKL, TRANCE, OPGL and CD254, is a single-pass type II membrane protein that belongs to the tumor necrosis factor family. The receptor activator of nuclear factor-kappaB ligand (RANKL), its cognate receptor RANK, and its natural decoy receptor osteoprotegerin have been identified as the final effector molecules of osteoclastic bone resorption. RANK and RANKL are key regulators of bone remodeling and regulate T cell/dendritic cell communications, and lymph node formation. Moreover, RANKL and RANK are expressed in mammary gland epithelial cells and control the development of a lactating mammary gland during pregnancy. Genetically, RANKL and RANK are essential for the development and activation of osteoclasts and bone loss in response to virtually all triggers tested. Inhibition of RANKL function via the natural decoy receptor osteoprotegerin (OPG, TNFRSF11B) prevents bone loss in postmenopausal osteoporosis and cancer metastases. Importantly, RANKL appears to be the pathogenetic principle that causes bone and cartilage destruction in arthritis. RANK-RANKL signaling not only activates a variety of downstream signaling pathways required for osteoclast development, but crosstalk with other signaling pathways also fine-tunes bone homeostasis both in normal physiology and disease. In addition, RANKL and RANK have essential roles in lymph node formation, establishment of the thymic microenvironment, and development of a lactating mammary gland during pregnancy.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
| 偶联 | Unconjugated |
| 免疫原 | Recombinant Human RANKL / OPGL / TNFSF11 / CD254 Protein (TMPY-03364) |
| 抗原种属 | Human |
| 研究领域 | Cancer Drug Targets |
存储&运输
| 储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| 运输方式 | Shipping with blue ice. |
SCI 文献
计算器
比如您的给药剂量是 10 mg/kg ，每只动物体重 20 g ，给药体积 100 μL ， 
评论列表
预览
Related Tags: buy Anti-RANKL/TNFSF11/CD254 Antibody (5P597) | purchase Anti-RANKL/TNFSF11/CD254 Antibody (5P597) | Anti-RANKL/TNFSF11/CD254 Antibody (5P597) cost | order Anti-RANKL/TNFSF11/CD254 Antibody (5P597)
嗨！有任何问题？点我咨询
评论内容